Clinical implications of loss of interruption variants for diagnosis, genetic counselling, and clinical trials in Huntington's disease
Journal of Huntington's Disease · 2026
DOI: 10.1177/18796397261443135 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Huntington's Disease, 2026. Verfasst von Hailey Findlay Black und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada. Hauptthemen laut MEDLINE: Huntington Disease, Genetic Counseling, Huntingtin Protein, Clinical Trials as Topic. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: James Family, Canadian Institutes of Health Research, BC Children's Hospital.
Abstract (Originalsprache)
Age of onset in Huntington disease (HD) is influenced by cis- acting genetic variants, particularly the loss of interrupting codons in the HTT CAG and CCG repeats (CAG-CCG LOI variant). The CAG-CCG LOI variant is not detectable by current diagnostic assays, leading to underestimation of CAG repeat length, misdiagnosis, and inaccurate prediction of risk of symptom onset in the reduced penetrance range. In clinical trials, unidentified CAG-CCG LOI variants may affect interpretation of results, particularly for small trials. Accurate ascertainment and reporting of the CAG-CCG LOI genotype therefore has important implications for HD diagnosis, genetic counselling, and clinical trial design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada.
ORCID-Profile: Hailey Findlay Black, Jessica Levesley, Chris Kay, Kyla Javier, Michael R Hayden
Förderung
- James Family
- Canadian Institutes of Health Research
- BC Children's Hospital
Zitieren
APA
Findlay Black, H., Levesley, J., Kay, C., Bortnick, S., Javier, K., & Hayden, M. R. (2026). Clinical implications of loss of interruption variants for diagnosis, genetic counselling, and clinical trials in Huntington's disease. Journal of Huntington's Disease. https://doi.org/10.1177/18796397261443135
Vancouver
Findlay Black H, Levesley J, Kay C, Bortnick S, Javier K, Hayden MR. Clinical implications of loss of interruption variants for diagnosis, genetic counselling, and clinical trials in Huntington's disease. Journal of Huntington's Disease. 2026. doi:10.1177/18796397261443135
BibTeX
@article{FindlayBlack2026,
author = {Findlay Black, Hailey and Levesley, Jessica and Kay, Chris and Bortnick, Stephanie and Javier, Kyla and Hayden, Michael R},
title = {Clinical implications of loss of interruption variants for diagnosis, genetic counselling, and clinical trials in Huntington's disease},
journal = {Journal of Huntington's Disease},
year = {2026},
doi = {10.1177/18796397261443135}
}
EUVIMED